Literature DB >> 22976141

Patterns of intracranial glioblastoma recurrence after aggressive surgical resection and adjuvant management: retrospective analysis of 43 cases.

Yoshiyuki Konishi1, Yoshihiro Muragaki, Hiroshi Iseki, Norio Mitsuhashi, Yoshikazu Okada.   

Abstract

The present retrospective study evaluated the recurrence patterns after aggressive surgical removal of intracranial glioblastomas in 43 consecutive adult patients. The resection rate of the enhanced lesion on magnetic resonance imaging was 100% and 95-99% in 22 and 21 cases, respectively. All patients received postoperative fractionated radiotherapy (60 Gy in 30 fractions) with additional chemotherapy (25 cases) or vaccine therapy (18 cases). During follow-up (median 17 months), tumor recurrence was identified in 33 patients, most frequently regional within the wall of the resection cavity (20 cases). No clinical factor differed significantly between the groups of patients with regional or marginal tumor progression (N = 22) and patients with distant or multiple recurrences (N = 8). Progression-free survival did not differ significantly between these two groups (p = 0.27). However, overall survival was significantly longer (p = 0.04) in patients with regional or marginal tumor progression, and constituted 90% and 54% at 1 and 2 years after surgery, respectively, compared to 75% and 0% in patients with distant or multiple recurrences. Aggressive surgical resection and adjuvant management of intracranial glioblastoma may change its recurrence pattern. Tumor progression appears in the wall of the resection cavity or within 2 cm from its margin in approximately half of patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22976141     DOI: 10.2176/nmc.52.577

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  16 in total

Review 1.  Insights into molecular therapy of glioma: current challenges and next generation blueprint.

Authors:  Y Rajesh; Ipsita Pal; Payel Banik; Sandipan Chakraborty; Sachin A Borkar; Goutam Dey; Ahona Mukherjee; Mahitosh Mandal
Journal:  Acta Pharmacol Sin       Date:  2017-03-20       Impact factor: 6.150

2.  Macrophage Exclusion after Radiation Therapy (MERT): A First in Human Phase I/II Trial using a CXCR4 Inhibitor in Glioblastoma.

Authors:  Reena P Thomas; Seema Nagpal; Michael Iv; Scott G Soltys; Sophie Bertrand; Judith S Pelpola; Robyn Ball; Jaden Yang; Vandana Sundaram; Jonathan Lavezo; Donald Born; Hannes Vogel; J Martin Brown; Lawrence D Recht
Journal:  Clin Cancer Res       Date:  2019-09-19       Impact factor: 12.531

3.  DWI for Monitoring the Acute Response of Malignant Gliomas to Photodynamic Therapy.

Authors:  Y Fujita; T Sasayama; K Tanaka; K Kyotani; H Nagashima; M Kohta; H Kimura; A Fujita; E Kohmura
Journal:  AJNR Am J Neuroradiol       Date:  2019-11-21       Impact factor: 3.825

4.  Neuroimaging classification of progression patterns in glioblastoma: a systematic review.

Authors:  Rory J Piper; Keerthi K Senthil; Jiun-Lin Yan; Stephen J Price
Journal:  J Neurooncol       Date:  2018-03-30       Impact factor: 4.130

5.  Tumor microtubes convey resistance to surgical lesions and chemotherapy in gliomas.

Authors:  Sophie Weil; Matthias Osswald; Gergely Solecki; Julia Grosch; Erik Jung; Dieter Lemke; Miriam Ratliff; Daniel Hänggi; Wolfgang Wick; Frank Winkler
Journal:  Neuro Oncol       Date:  2017-10-01       Impact factor: 12.300

6.  EXPANDS: expanding ploidy and allele frequency on nested subpopulations.

Authors:  Noemi Andor; Julie V Harness; Sabine Müller; Hans W Mewes; Claudia Petritsch
Journal:  Bioinformatics       Date:  2013-10-30       Impact factor: 6.937

Review 7.  Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect.

Authors:  Hayley Nehoff; Neha N Parayath; Laura Domanovitch; Sebastien Taurin; Khaled Greish
Journal:  Int J Nanomedicine       Date:  2014-05-22

8.  Evaluation of high-grade astrocytoma recurrence patterns after radiotherapy in the era of temozolomide: A single institution experience.

Authors:  Arno Lotar Cordova; Taynná Vernalha Rocha Almeida; Cintia Mara da Silva; Pedro Argolo Piedade; Cristiane Maria Almeida; Carlos Genesio Bezzera Lima; Carolina Dutra; Rafael Martins Ferreira; Marcelo Neves Linhares; Valeriy Denyak
Journal:  Rep Pract Oncol Radiother       Date:  2018-03-17

9.  Factors associated with a higher rate of distant failure after primary treatment for glioblastoma.

Authors:  Sonia Tejada; Guillermo Aldave; Miguel Marigil; Jaime Gállego Pérez-Larraya; Jaime de Gallego; Pablo Daniel Domínguez; Ricardo Díez-Valle
Journal:  J Neurooncol       Date:  2013-10-18       Impact factor: 4.130

10.  Intraoperative Photodynamic Diagnosis Using Talaporfin Sodium Simultaneously Applied for Photodynamic Therapy against Malignant Glioma: A Prospective Clinical Study.

Authors:  Kazuhide Shimizu; Masayuki Nitta; Takashi Komori; Takashi Maruyama; Takayuki Yasuda; Yu Fujii; Ken Masamune; Takakazu Kawamata; Taketoshi Maehara; Yoshihiro Muragaki
Journal:  Front Neurol       Date:  2018-01-30       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.